

Ketamine for Anxiety
Anxiety disorders are among the most common mental health conditions in the United States, affecting more than 40 million adults each year [1]. For many, the daily struggle with racing thoughts, irritability, and physical symptoms like rapid heartbeat or dizziness can be debilitating—and traditional treatments don’t always provide the relief they need.
At Cascade Mind & Body Clinic, we offer ketamine infusion therapy as a cutting-edge option for individuals experiencing treatment-resistant anxiety. If you’ve tried therapy or medications with limited success, ketamine may offer a new path forward.

Fast & Effective Anxiety Treatment
Relief without the wait—now available at Cascade Mind & Body Clinic
​
Research shows that low-dose ketamine infusions can quickly and effectively reduce anxiety symptoms—even in patients who have not responded to other treatments [2][3]. Unlike traditional antidepressants, which may take weeks to months to show results, ketamine can relieve symptoms in a matter of hours or days [4].
Ketamine works by targeting the glutamate system, an essential neurotransmitter network responsible for mood regulation and stress response. By acting as an NMDA receptor antagonist, ketamine disrupts patterns associated with anxiety and helps promote new neural growth, supporting long-term emotional resilience [5].
​
“Ketamine is providing rapid relief of anxiety and fear symptoms in treatment-resistant patients who have not benefited from other therapies.”
— Journal of Psychopharmacology [3]​
Common Symptoms of Anxiety
Each person’s experience with anxiety is unique, but some of the most frequently reported symptoms include:
-
Racing or intrusive thoughts
-
Difficulty concentrating
-
Excessive worry or overthinking
-
Irritability
-
Rapid breathing or heart rate
-
Dizziness or lightheadedness
-
Sweating, hot flashes, or blushing
-
Sleep disturbances
If these symptoms interfere with your daily life and haven’t responded to therapy or medication, ketamine may be an option worth exploring.
​
References
-
National Institute of Mental Health (NIMH). Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders
-
Glue P et al. (2017). Effects of ketamine in treatment-resistant generalized anxiety and social anxiety disorders. J Psychopharmacol. https://doi.org/10.1177/0269881116689050
-
Feder A et al. (2014). Efficacy of intravenous ketamine for treatment of chronic PTSD. JAMA Psychiatry.https://doi.org/10.1001/jamapsychiatry.2014.62
-
Taylor JH et al. (2018). Ketamine for social anxiety disorder: A randomized, placebo-controlled crossover trial. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0007-3
-
Duman RS, Aghajanian GK. (2012). Synaptic dysfunction in depression and anxiety: potential therapeutic targets. Science. https://doi.org/10.1126/science.1222939
-
Feder A, Costi S, et al. (2021). Efficacy and safety of repeated ketamine infusions for treatment-resistant anxiety. Depression and Anxiety. https://doi.org/10.1002/da.23161